Passionate oligonucleotide chemist with three years of experience in oligonucleotide synthesis, purification, and analysis. Adept at project management both individually and on a group scale through mentorship. Spearheading a new research direction in Dr. Khalid Salaita's lab by synergizing the programmability of oligonucleotides with the potent drug efficacies of proteolysis targeting chimeras (PROTACs).
Awards:
Representative publication: